Market Definition

High throughput screening (HTS) is a technique used to explore and design new pharmaceutical products. Several steps are required, including detection, reagent preparation, compound management, natural acoustic, and high-throughput library screening. A huge variety of synthetic effectors and modulators are screened against a specific target in this procedure, which takes several hours to complete. Furthermore, use of such high-throughput screening techniques can help to lower the overall cost of drug development. Furthermore, this technique allows for the screening of a large number of compounds using high-throughput screening (HTS), with the ability to screen up to at least 10,000 compounds per day, and the use of ultrahigh-throughput screening (UHTS) allowing for the screening of up to 100,000 assays per day. Robots, detectors, and software are used in conjunction with this method to control the whole process. Besides that, it is utilised for screening a variety of various kinds of libraries, including combinatorial chemistry, peptides and genetics libraries, as well as proteomics libraries. It is also used in the characterization of metabolic, pharmacokinetic, and toxicological data associated with novel medications. 

Increased usage of high-throughput screening for drug development, which lowers the amount of time required to create a medication, is anticipated to drive massive increase in the worldwide high-throughput screening market in the upcoming years.The availability of government financing and entrepreneurial capital investments, as well as an increase in Dividend payout by pharmaceutical firms, are the primary drivers of market expansion. The burgeoning rate of drug targets for screening, which would then be utilised for drug discovery and development, as well as increasing expenditures by governments and academic institutions, are one of the major factors driving market expansion. Expanding applicability in biosciences research, as well as developing countries, are anticipated to offer growth prospects for companies in the HTS industry.An increase in automated in the area of high throughput screening, as well as quicker data processing, contribute to the expansion of the market. Certain constraints, such as expensive capital expenditures and a scarcity of qualified experts in emerging and undeveloped nations, are preventing the market for high-throughput screening from expanding. When looking at the market by technology, it is expected to grow at a faster rate mostly during the projected timeline. This is due to the fact that product technology provides simple methods for studying complex biological pathways and reduces the risk of drug failure caused by toxic effects, which both leads to the enhancement of the high throughput screening industry.

Report Scope

The global market report scope consists of a comprehensive study covering primary factors impacting the industry trends. The study includes analysis of regional and country-level market dynamics. The scope also consists of competitive overview offering company market shares coupled with company profiles for key revenue contributing companies. The report scope covers a detailed competitive outlook covering market shares and profiles of key participants in the market share.

Major Market Players

The report offers the major market player’s profiles, such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).

The High throughput screening Market report has been categorized as below

By Product & Service

  • Consumables

    • Reagents & Assay Kits

    • ;Laboratory Equipment

  • Instruments

    • Liquid Handling Systems

    • Detection Systems

    • Other Instruments

  • Services

  • Software

By Technology

  • Cell-based Assays

    •  2D Cell Culture

    • 3D Cell Culture

      • Scaffold-based Technology

        • Hydrogels

          • Animal-derived Hydrogels

            • Matrigel

            • Collagen

          • Synthetic Hydrogels

          • Alginate/Agarose

        • Inert Matrix/Solid Scaffolds

        • Micropatterned Surfaces

      • Scaffold-free Technology

        • Ultra-low Binding Plates   

        • Hanging-drop Plates

        • Other Scaffold-free Technologies

    • Reporter-based Assays

    • Perfusion Cell Culture

  • Lab-on-a-Chip Technology (LOC)

  • Label-free Technology

By Application

  • Drug Discovery

  • Biochemical Screening

  • Life Sciences Research

By End User

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Contract Research Organizations (CROs)

Based on regions:

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The years considered for the study are as follows:

  • Base year - 2020
  • Estimated year - 2021
  • Projected year – 2022
  • Forecast period - 2021 to 2027

Key Questions Addressed by the Report

  • New products/service competitors are exploring?
  • Key players in the High throughput screening Market and how extreme is the competition?
  • What are the future market trends that manufacturers are emphasizing on in the future updates?
  • For each segment, what are the crucial opportunities in the market?
  • What are the key growth strategies embraced by key market players in the market?
  • What are the key success strategies adopted by major competitors in the market?

Why Buy this Report:

  • Obtain comprehensive insights on the  High throughput screening market trends
  • Note comprehensive analysis of the market status
  • Identifies the market opportunities and growth segments
  • Assessing business segments & product portfolios, and explain competitive dynamics
  • Provide strategy planning and industry dynamics to strengthen decision making

Table of content 

1. Global  High throughput screening Market Introduction

1.1. Key Insights

1.2. Report Overview

1.3. Markets Covered

1.4. Stakeholders

2. Research Methodology

2.1. Research Scope

2.2. Market Research Process

2.3. Research Data Analysis

2.4. Market Size Estimation

3. Executive Summary 

4. Market Overview

4.1. Introduction

4.2. Market Drivers and Restraints

5. By Product & Service

5.1.  Consumables

5.1.1.  Reagents & Assay Kits

5.1.2. Laboratory Equipment

5.2. Instruments

5.2.1. Liquid Handling Systems

5.2.2. Detection Systems

5.2.3. Other Instruments

5.3. Services

5.4. Software

6. By Technology

    6.1.  Cell-based Assays

        6.1.1.  2D Cell Culture

        6.1.2. 3D Cell Culture

            6.1.2.1. Scaffold-based Technology

            6.1.2.2. Hydrogels

            6.1.2.3. Animal-derived Hydrogels

            6.1.2.4. Matrigel

            6.1.2.5. Collagen

            6.1.2.6. Synthetic Hydrogels

            6.1.2.7. Alginate/Agarose

            6.1.2.8. Inert Matrix/Solid Scaffolds

            6.1.2.9. Micropatterned Surfaces

            6.1.2.10. Scaffold-free Technology

            6.1.2.11. Ultra-low Binding Plates   

            6.1.2.12. Hanging-drop Plates

            6.1.2.13. Other Scaffold-free Technologies

        6.1.3. Reporter-based Assays

        6.1.4. Perfusion Cell Culture

    6.2. Lab-on-a-Chip Technology (LOC)

    6.3. Label-free Technology

7. By Application

7.1.  Drug Discovery

7.2.  Biochemical Screening

7.3. Life Sciences Research

8. By End User

8.1.  Pharmaceutical & Biotechnology Companies

8.2.  Academic & Research Institutes

8.3. Contract Research Organizations (CROs)

9. By regions:

9.1.  Key points 

9.2.  North America

9.3. Europe

9.4. Asia Pacific

9.5. Rest of World

10. Company Profile

(Profile contain company overview, products/services, financials & recent developments)

10.1. Thermo Fisher Scientific Inc. (US) 

10.2. Agilent Technologies, Inc. (US) 

10.3. Danaher Corporation (US)

10.4. PerkinElmer, Inc. (US)

10.5. Tecan Group Ltd. (Switzerland) 

10.6. AXXAM S.p.A. (Italy)

10.7. Merck KGaA (Germany)

10.8. Bio-Rad Laboratories, Inc. (US) 

10.9. Promega Corporation (US)

10.10. Corning Incorporated (US)

10.11. Eurofins Scientific (Luxembourg).

The High throughput screening Market report has been categorized as below

By Product & Service

  • Consumables

    • Reagents & Assay Kits

    • ;Laboratory Equipment

  • Instruments

    • Liquid Handling Systems

    • Detection Systems

    • Other Instruments

  • Services

  • Software

By Technology

  • Cell-based Assays

    •  2D Cell Culture

    • 3D Cell Culture

      • Scaffold-based Technology

        • Hydrogels

          • Animal-derived Hydrogels

            • Matrigel

            • Collagen

          • Synthetic Hydrogels

          • Alginate/Agarose

        • Inert Matrix/Solid Scaffolds

        • Micropatterned Surfaces

      • Scaffold-free Technology

        • Ultra-low Binding Plates   

        • Hanging-drop Plates

        • Other Scaffold-free Technologies

    • Reporter-based Assays

    • Perfusion Cell Culture

  • Lab-on-a-Chip Technology (LOC)

  • Label-free Technology

By Application

  • Drug Discovery

  • Biochemical Screening

  • Life Sciences Research

By End User

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Contract Research Organizations (CROs)

Based on regions:

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Licence Option

  • Single User 1500 USD
  • Multiple User 3500 USD

Quality assurance

A testimonial for service in the form of BBB “A” Accreditation.

Your personal and confidential information is safe and secure.

  - Information security

© 2021 Whipsmart. All Rights Reserved.

Terms of use| Site Map